Demonstrating potential safety and efficacy of WEE1 inhibitor, ATRN-1051, in the treatment of ovarian cancer Company anticipates submitting an IND…
SOLANA BEACH, Calif. and REDWOOD CITY, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader…
Robert E. Landry to retire effective February 2024; Christopher Fenimore, long-standing Senior Vice President, Head of Accounting and Controller, to…
Kathryn Guarini, Ph.D., and David P. Schenkein, M.D., join Regeneron’s Board of DirectorsTARRYTOWN, N.Y., Sept. 08, 2023 (GLOBE NEWSWIRE) --…
BERKELEY HEIGHTS, N.J., Sept. 08, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and…
Highlights AHI enters collaboration with His Excellency Dr Obaid Alketbi.Bin Farhood Group Founders have worked with and within the Government…
TORONTO, ON / ACCESSWIRE / September 7, 2023 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), is a clinical…
Utilizing AI to accelerate research and development for drug discovery and biological studies. MELVILLE, N.Y., Sept. 7, 2023 /PRNewswire/ --…
CAMPBELL, Calif., Sept. 7, 2023 /PRNewswire/ -- Body Vision Medical, a leader in AI-driven intraoperative imaging, and Mediflex, a leading…
NEW YORK, Sept. 7, 2023 /PRNewswire/ -- New York Cancer & Blood Specialists (NYCBS), one of the nation's leading oncology…